<DOC>
	<DOCNO>NCT00134654</DOCNO>
	<brief_summary>The purpose study see Premarin useful androgen-independent prostate cancer help understand drug Premarin may work .</brief_summary>
	<brief_title>Two Doses Conjugated Estrogen ( Premarin ) Patients With Androgen-Independent Prostate Cancer</brief_title>
	<detailed_description>Patients randomly assign one two study group ( arm A Arm B ) . Arm A receive 1.25mg Premarin daily arm B receive 1.25mg Premarin three time day . Patients also receive coumadin daily help prevent thromboembolic disease . After review first 30 patient Arm A , determine arm A ( low dose Premarin ) effective . Arm A closed patient Arm A give choice switch Arm B . Treatment continue evidence disease progression unacceptable side effect . Every 4 week receive Premarin , physical exam blood work perform . Every 12 week CT scan abdomen pelvis bone scan perform . Patients also encourage undergo standard preventative breast irradiation prior start Premarin 4 week start treatment .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Documented histologic evidence prostate cancer . Progressive androgenindependent prostate cancer define ProstateSpecific Antigen ( PSA ) Working Group conventional androgen deprivation antiandrogen withdrawal . PSA &gt; 2ng/ml serum testosterone &lt; 50ng/ml No history thromboembolic disease within prior year ECOG performance status 02 Creatinine &lt; 2 x upper limit normal Bilirubin &lt; 2 x upper limit normal AST &lt; 2 x upper limit normal Unstable angina change anginal symptom within past 6 month . Prior therapy estrogens PCSPECS . Concurrent megestrol acetate steroid hormone Major surgery radiation therapy within 4 week Strontium89 samarium153 therapy within 8 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Androgen-independent prostate cancer</keyword>
	<keyword>Premarin</keyword>
	<keyword>conjugate estrogen</keyword>
</DOC>